Biotech Values

[stocksrising]

Anybody following Protara( TARA) and its advancement in NMIBC ( ..announced positive data from three-month evaluable carcinoma in situ (CIS) patients treated across its ongoing clinical program of TARA-002, the Company’s investigational cell-based therapy, in high-risk Non-Muscle Invasive Bladder Cancer (NMIBC), including Bacillus Calmette-Guérin (BCG)-Unresponsive, BCG-Experienced and BCG-Naïve patient populations.

and IV Choline Chloride (IV Choline Chloride has the potential to become the first FDA-approved IV formulation of choline for the 40,000 PN patients in the U.S.
Approximately 80% of PN patients are choline deficient, which can lead to liver damage and hepatic failure; ASPEN recommends choline replacement for PN patients)

https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-alignment-fda-registrational-path

https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-positive-three-month-data-tara

https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-oversubscribed-45-million-private

Small float, cash runway I believe to Q1, 2026(completed PP ~$45mm)

( have sizable position, not trying to talk book but just curious the potential in both Indications)????
Thanks in advance !